Clinical outcomes of CAR-T cell therapy in 21 patients with relapsed or refractory B-cell lymphoma involving the ileocecal region. // Digital Chinese Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1465324926009965?dgcid=rss_sd_all
Clinical outcomes of CAR-T cell therapy in 21 patients with relapsed or refractory B-cell lymphoma involving the ileocecal region. Digital Chinese Medicine. https://www.sciencedirect.com/science/article/pii/S1465324926009965?dgcid=rss_sd_all
“Clinical outcomes of CAR-T cell therapy in 21 patients with relapsed or refractory B-cell lymphoma involving the ileocecal region.” Digital Chinese Medicine.
@article{article5294,
title = {Clinical outcomes of CAR-T cell therapy in 21 patients with relapsed or refractory B-cell lymphoma involving the ileocecal region},
journal = {Digital Chinese Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1465324926009965?dgcid=rss_sd_all}
}
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Matic Bartol, Tina Fink, Tina Tragin, Ema Pleško, Roman Jerala, Hana Esih, Aljaž Kravanja, Brina Štante, Valentina Bianco, Luka Fajs, Mojca Jež